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asked to complete each assessment two days apart. The analyses
tested for mean differences (repeated measures ANOVA) and
reliability (intraclass correlation coefﬁcient [ICC]) to assess mea-
surement stability over time. Equivalence of the means was estab-
lished if the 95% conﬁdence interval (CI) of the mean difference
was within the minimally important difference (MID) interval:
-0.035 to .035 for the index and -3 to 3 for the EQ VAS.
Adequacy of the ICC was established by comparing the ICC 95%
lower CI with a critical value of 0.70. RESULTS: The per pro-
tocol analysis included 109 subjects for the EQ VAS and 113
subjects for the index. For the EQ-5D index, the means (SD) of
the paper and IVR administrations were 0.790 (0.172) and 0.800
(0.180), respectively. The 95% CI of the mean difference was
-0.024 to 0.006, which was within the equivalence interval. The
ICC was 0.894 (95% lower CI 0.857), signiﬁcantly different
from 0.70. For the EQ VAS, the means (SD) were 72.0 (19.7) for
paper and 74.1 (19.8) for IVR. The 95% CI of the mean differ-
ence was -3.784 to -0.484, partially within the equivalence
interval. The ICC was 0.897 (95% lower CI 0.859) also signiﬁ-
cantly different from 0.70. CONCLUSIONS: This analysis pro-
vides evidence that the EQ-5D scores on the IVR version were
equivalent to those obtained on the original paper version.
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OBJECTIVES: Cancer-related fatigue (crF) is a frequently
reported complaint in cancer patients and survivors. The Perform
Questionnaire (PQ) is a recently validated 12-item scale to assess
perceptions and beliefs about crF throughout the dimensions
‘Physical limitations’, ‘Activities of daily living’, ‘Beliefs and atti-
tudes’. This study aims to explore the performance of different
ways for identifying stable patients in the assessment of test-retest
reliability. METHODS: Patients with a moderate level of crF
participated in an observational and longitudinalmulti-centre. PQ
and a 100 mm horizontal visual analogue scale for fatigue inten-
sity (VAS) were administered at inclusion and 3 months later.
Stability concerning crF was deﬁned as either: 1) absence of
self-reported health change, using a standard self-administered
health status item (HSI) at the second visit on a Likert-type ordinal
scale with 13 response options, or 2) Fatigue VAS score change
between visits <5 mm. Test-retest reliability (Intraclass correlation
coefﬁcient, ICC) was assessed for the PQ overall and for the three
dimension scores, using each method 1 and 2.RESULTS: Baseline
sample characteristics (n = 437) were: 60.5% women, mean age
59.1 years, an average of 2.21 years since diagnosis, 33.6% breast
cancer, 54.7% with metastasis, Karnofsky mean score 80.9, and
29.1% with anaemia. ICC values obtained using the method 1
(n = 58) didn’t reach the standard value recommended (0.70) for
the overall (0.68) neither the dimension scores (0.52–0.68), while
ICC values obtained using themethod 2 (n = 64) were satisfactory
and reached the standards accepted for this psychometric proper-
tie assessment (0.83 for the overall score and ranging between
0.77 and 0.84 for the three dimension scores). CONCLUSIONS:
Patient-perspective is a relevant approach in the assessment of the
psychometric properties of the patient-oriented health outcomes
measures. The performance and adequacy of different patient-
perspective criteria can conduct to different conclusions concern-
ing speciﬁc psychometric properties.
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OBJECTIVES: Among patients with cancer and other diseases,
pain is a common experience that can negatively impact daily
living. It is unclear whether pain experiences and their impact are
diagnosis-speciﬁc or shared across conditions. We examined
whether the United States general population-based PROMIS
Pain Impact item bank can be used for measuring cancer pain,
and the relationship between pain experience and pain impact.
METHODS: PROMIS Pain Impact items included in ﬁeld testing
with oncology populations were selected through expert consen-
sus. Multidisciplinary clinical input was obtained to ensure
content coverage and the relevance of PROMIS pain items to
cancer. Items’ psychometric properties were reviewed when
applicable. As a result, PROMIS-Ca Pain Impact consisted of 36
items across 3 areas: physical, emotion and social. The sample
included 529 cancer patients (74% female, 82% White, mean
age = 56). Analyses included item scalability (item-scale correla-
tion >0.3), unidimensionality (exploratory and conﬁrmatory
factor analysis, and multidimensional scaling), and IRT model ﬁt
(S2-G2 & S2-X2). RESULTS: All 36 PROMIS-Ca Pain Impact
items met preset analysis criteria to form a unidimensional item
bank. Additional analyses showed that scores from Pain Impact
were signiﬁcantly correlated with Pain Quality items assessing
pain intensity (r = 0.56), frequency (r = 0.58) and duration
(r = 0.64), and could signiﬁcantly differentiate patients with dif-
ferent degrees of neuropathic pain, F(4527) = 37.4, p < 0.0001,
emotional distress as measured by two items F(4472) = 122.53,
p < 0.001, and F(4453) = 74.94, p < 0.001. Similar results were
found regardless of whether patients based their responses on
their “worst” or “least” pain experience. CONCLUSIONS:
PROMIS-Ca Pain is a psychometrically-sound and clinically
meaningful measure for cancer patients. It is correlated with
patients’ pain experience. Our next step is to examine whether
the same conclusion can be made with other disease groups.
Ultimately, a statistical cross-walk of pain scores could be created
to enable the comparison of pain scores between disease groups.
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OBJECTIVES: Analyses of patients’ preferences about their
therapies are a prerequisite for shared decision making, but are
still not widely performed. This study elaborates the importance
of treatment aspects in the eyes of multiple myeloma (MM)
patients using direct assessment and Discrete-Choice-
Experiments (DCE). METHODS: After a literature review we
conducted focus groups with 6–8 MM patients to collect the
most important therapy aspects. Then, patients answered an
online or paper-pencil questionnaire which asked for sociodemo-
graphic data, self-rated-health (SF12v2 variation) and patients’
preferences about therapy. The latter were assessed using direct
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